{
    "nct_id": "NCT03329131",
    "official_title": "Evaluation of Cryotherapy and TRPA1 Receptors in Chemotherapy Induced Neuropathy",
    "inclusion_criteria": "* Histologically confirmed diagnosis of early stage breast cancer (stage I-III).\n* Planned to receive treatment with either adjuvant or neo-adjuvant taxane-based chemotherapy.\n* Age > 18 years. There is no upper age limit for participation in this study.\n* Patients may have received any of the following therapies: surgery, chemotherapy, hormones, biologics, or radiation.\n* Prior chemotherapies are permitted, except with prior treatments with taxanes, vinca alcaloids, gemcitabine, eribulin, ixabepilone, platinum drugs)\n* All patients will have given signed, informed consent prior to registration\n* Patients must have a performance status of ECOG 0 or 1.\n\nExclusion Criteria\n\n* Patients must not have received any prior taxane or platinum based chemotherapy.\n* Patients must not have a history of peripheral neuropathy (regardless of cause).\n* Patient must not have a history of Raynaud's disease.\n* Patients with partial or complete limb amputations.\n* Known hypersensitivity to cold\n* Patient cannot be on the following medications: GABA analogues (such as Neurontin, lyrica), tricyclic antidepressants (such as amitriptyline or nortriptyline)\n* As judged by the investigator, severe uncontrolled concurrent medical conditions, psychiatric illness or social condition that would limit compliance with study requirements.\n* Evidence of any significant clinical disorder or laboratory finding that makes it undesirable for the subject to participant in the clinical trial\n* Must not be pregnant or breast feeding\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
    "exclusion_criteria": "",
    "miscellaneous_criteria": ""
}